Lynparza notches first in POLO trial of pancreatic cancer

By Erin McCallister | Feb 26, 2019 | 5:50 PM GMT

Editor's Note: This article was updated on Feb 26, 2019 at 10:24 PM GMT

AstraZeneca plc (LSE:AZN; NYSE:AZN) and partner Merck & Co. Inc. (NYSE:MRK) announced the first positive data for

Read the full 177 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD